Are severe asthma patients at higher risk of developing severe outcomes from COVID-19?
作者信息
Kow Chia Siang, Capstick Toby, Hasan Syed Shahzad
机构信息
School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia.
Leeds Teaching Hospitals NHS Trust, St. James's University Hospital, Leeds, United Kingdom.
出版信息
Allergy. 2021 Mar;76(3):959-960. doi: 10.1111/all.14589. Epub 2020 Oct 2.
Abstract
摘要
相似文献
1
Are severe asthma patients at higher risk of developing severe outcomes from COVID-19?重度哮喘患者发生 COVID-19 严重后果的风险更高吗？
Allergy. 2021 Mar;76(3):959-960. doi: 10.1111/all.14589. Epub 2020 Oct 2.
2
Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19?回复：Kow CS等人。重症哮喘患者发生COVID-19严重后果的风险更高吗？
Allergy. 2021 Mar;76(3):961-962. doi: 10.1111/all.14593.
3
Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.新型冠状病毒病 2019 与哮喘、变应性鼻炎：分子机制与宿主-环境相互作用。
Curr Opin Allergy Clin Immunol. 2021 Feb 1;21(1):1-7. doi: 10.1097/ACI.0000000000000699.
4
Real-life survey on severe asthma patients during COVID-19 lockdown in Italy.意大利 COVID-19 封锁期间严重哮喘患者的真实生活调查。
Expert Rev Respir Med. 2021 Aug;15(8):1057-1060. doi: 10.1080/17476348.2021.1917387. Epub 2021 Apr 25.
5
Distinct effects of asthma and COPD comorbidity on disease expression and outcome in patients with COVID-19.哮喘与慢性阻塞性肺疾病（COPD）共病对新型冠状病毒肺炎（COVID-19）患者疾病表现及预后的不同影响。
Allergy. 2021 Feb;76(2):483-496. doi: 10.1111/all.14517. Epub 2020 Aug 11.
6
The effect of allergy and asthma as a comorbidity on the susceptibility and outcomes of COVID-19.过敏和哮喘作为合并症对 COVID-19 的易感性和结局的影响。
Int Immunol. 2022 Mar 25;34(4):177-188. doi: 10.1093/intimm/dxab107.
7
Low prevalence of asthma in Mexican children and adults with a positive rtRT-PCR test for SARS-CoV-2: a cross-sectional study during the 2020 pandemic.2020年疫情期间一项横断面研究：SARS-CoV-2逆转录实时聚合酶链反应（rtRT-PCR）检测呈阳性的墨西哥儿童和成人中哮喘的低患病率
Allergol Immunopathol (Madr). 2021 May 1;49(3):1-7. doi: 10.15586/aei.v49i3.7. eCollection 2021.
8
Clinical course and outcomes of patients with asthma hospitalized for severe acute respiratory syndrome coronavirus 2 pneumonia: A single-center, retrospective study.因严重急性呼吸综合征冠状病毒2型肺炎住院的哮喘患者的临床病程及结局：一项单中心回顾性研究。
Ann Allergy Asthma Immunol. 2020 Dec;125(6):707-709. doi: 10.1016/j.anai.2020.07.029. Epub 2020 Aug 1.
9
[Asthma and COVID-19].[哮喘与2019冠状病毒病]
Rev Alerg Mex. 2022;69 Suppl 1:s15-s23. doi: 10.29262/ram.v69iSupl1.1009.
10
Is asthma an exclusionary condition for SARS-CoV-2 infection in China? -the relationship between asthma and COVID-19.哮喘是否是中国 SARS-CoV-2 感染的排除条件？——哮喘与 COVID-19 的关系。
J Asthma. 2021 Oct;58(10):1337-1339. doi: 10.1080/02770903.2020.1789873. Epub 2020 Aug 4.
引用本文的文献
1
A systematic two-sample and bidirectional MR process highlights a unidirectional genetic causal effect of allergic diseases on COVID-19 infection/severity.一项系统的两样本双向 MR 分析过程强调了过敏性疾病对 COVID-19 感染/严重程度的单向遗传因果效应。
J Transl Med. 2024 Jan 23;22(1):94. doi: 10.1186/s12967-024-04887-4.
2
A retrospective study regarding the influence of COVID-19 disease on asthma.一项关于 COVID-19 疾病对哮喘影响的回顾性研究。
BMC Pulm Med. 2023 Jan 17;23(1):22. doi: 10.1186/s12890-023-02309-7.
3
Causal Association and Shared Genetics Between Asthma and COVID-19.哮喘和 COVID-19 之间的因果关联和共同遗传。
Front Immunol. 2022 Mar 21;13:705379. doi: 10.3389/fimmu.2022.705379. eCollection 2022.
4
The Problems Experienced by Employees with Chronic Disease during the COVID-19 Pandemic.慢性疾病员工在 COVID-19 大流行期间所经历的问题。
Int J Environ Res Public Health. 2022 Jan 5;19(1):578. doi: 10.3390/ijerph19010578.
5
Recent advances and developments in COVID-19 in the context of allergic diseases.新冠病毒肺炎在过敏性疾病背景下的最新进展与动态
Clin Transl Allergy. 2021 Sep;11(7):e12065. doi: 10.1002/clt2.12065.
6
Severe asthma in the era of COVID-19: A narrative review.COVID-19 时代的严重哮喘：叙事性综述。
Pulmonology. 2022 Jan-Feb;28(1):34-43. doi: 10.1016/j.pulmoe.2021.04.001. Epub 2021 Apr 30.
7
Anti-IL5 Drugs in COVID-19 Patients: Role of Eosinophils in SARS-CoV-2-Induced Immunopathology.抗IL-5药物在新冠肺炎患者中的应用：嗜酸性粒细胞在SARS-CoV-2诱导的免疫病理学中的作用
Front Pharmacol. 2021 Mar 9;12:622554. doi: 10.3389/fphar.2021.622554. eCollection 2021.
8
Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19?回复：Kow CS等人。重症哮喘患者发生COVID-19严重后果的风险更高吗？
Allergy. 2021 Mar;76(3):961-962. doi: 10.1111/all.14593.
本文引用的文献
1
COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments.意大利重症哮喘网络（SANI）患者中的新型冠状病毒肺炎：临床特征、合并症的影响及治疗情况
Allergy. 2021 Mar;76(3):887-892. doi: 10.1111/all.14532. Epub 2020 Aug 20.
2
Common concerns in managing bronchial asthma during the COVID-19 pandemic.在新冠疫情期间管理支气管哮喘的常见问题。
Int J Tuberc Lung Dis. 2020 Jul 1;24(7):750-752. doi: 10.5588/ijtld.20.0378.
3
Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19.COVID-19 住院和非住院患者中哮喘的患病率和特征。
J Allergy Clin Immunol. 2020 Aug;146(2):307-314.e4. doi: 10.1016/j.jaci.2020.06.010. Epub 2020 Jun 15.
4
Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective.吸入性皮质类固醇与 COVID-19：系统回顾与临床观察。
Eur Respir J. 2020 May 7;55(5). doi: 10.1183/13993003.01009-2020. Print 2020 May.
Zotero 插件